Macquarie Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,372
| Closed | -$61K | – | 2079 |
|
|
2022
Q3 | $61K | Sell |
1,372
-250
| -15% | -$11.1K | ﹤0.01% | 1892 |
|
|
2022
Q2 | $45K | Hold |
1,622
| – | – | ﹤0.01% | 2077 |
|
|
2022
Q1 | $88 | Hold |
1,622
| – | – | ﹤0.01% | 1984 |
|
|
2021
Q4 | $95K | Hold |
1,622
| – | – | ﹤0.01% | 1953 |
|
|
2021
Q3 | $64K | Buy |
1,622
+1,372
| +549% | +$54.1K | ﹤0.01% | 2135 |
|
|
2021
Q2 | $11K | Hold |
250
| – | – | ﹤0.01% | 2460 |
|
|
2021
Q1 | $15K | Buy |
+250
| New | +$15K | ﹤0.01% | 2336 |
|